| Ticker Details |
IQVIA Holdings Inc.
IQVIA Holdings Inc is an information and technology-enabled healthcare service provider to the pharmaceutical services, biotechnology, and healthcare industries. The Commercial Solutions and Research and Development Solutions generate maximum revenue.
|
| IPO Date: |
May 9, 2013 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$39.79B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$2.38 | 1.31%
|
| Avg Daily Range (30 D): |
$4.07 | 1.84%
|
| Avg Daily Range (90 D): |
$3.80 | 2.02%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
1.05M |
| Avg Daily Volume (30 D): |
1.08M |
| Avg Daily Volume (90 D): |
1.26M |
| Trade Size |
| Avg Trade Size (Sh.): |
53 |
| Avg Trade Size (Sh.) (30 D): |
38 |
| Avg Trade Size (Sh.) (90 D): |
42 |
| Institutional Trades |
| Total Institutional Trades: |
9,543 |
| Avg Institutional Trade: |
$11.93M |
| Avg Institutional Trade (30 D): |
$17.55M |
| Avg Institutional Trade (90 D): |
$13.92M |
| Avg Institutional Trade Volume: |
.07M |
| Avg Institutional Trades (Per Day): |
4 |
| Market Closing Trades |
| Avg Closing Trade: |
$31.11M |
| Avg Closing Trade (30 D): |
$48.02M |
| Avg Closing Trade (90 D): |
$48.21M |
| Avg Closing Volume: |
170.6K |
|
|
| Financials |
| |
TTM |
Q2 2026 |
Q1 2026 |
|
Basic EPS
|
$8.12
|
$1.54
|
$1.63
|
|
Diluted EPS
|
$8.05
|
$1.53
|
$1.61
|
|
Revenue
|
$16.98B
|
$4.37B
|
$4.15B
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$1.38B
|
$258M
|
$275M
|
|
Operating Income / Loss
|
$2.2B
|
$506M
|
$514M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$-130M
|
$-38M
|
$-33M
|
|
PE Ratio
|
|
|
|
|
|
|
